Pasqal (NASDAQ:PSQL) Stock Keeps “Buy” Rating at Canaccord Genuity Group

Canaccord Genuity Group reiterated their buy rating on shares of Pasqal (NASDAQ:PSQL – Free Report) in a report published on Monday,Benzinga reports. They currently have a $16.00 price target on the stock.

A number of other research analysts also recently commented on PSQL. Roth Capital initiated coverage on Pasqal in a research report on Wednesday, September 9th. They set a “buy” rating and a $20.00 target price for the company. Zacks Research raised shares of Pasqal to a “hold” rating in a research note on Thursday, September 24th. Finally, UBS Group set a $16.00 target price on shares of Pasqal in a research note on Tuesday, September 22nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $17.33.

Get Our Latest Stock Analysis on Pasqal

Pasqal Stock Down 4.1%

Shares of Pasqal stock opened at $6.70 on Monday. Pasqal has a twelve month low of $6.60 and a twelve month high of $24.69.

Pasqal Company Profile

(Get Free Report)

Pasqal is a quantum computing company focused on developing neutral-atom quantum technology. The company designs quantum processors that use individually controlled atoms as qubits, along with the hardware, control systems and software needed to operate quantum computers.

Its offerings include access to quantum computing systems through cloud-based platforms, as well as software tools and services intended to help organizations develop and run quantum algorithms. Pasqal targets applications such as optimization, simulation, machine learning, drug discovery, energy and financial modeling.

Founded in France in 2019 by Georges-Olivier Reymond, Pasqal serves research institutions, corporations and public-sector organizations.

Featured Stories

Receive News & Ratings for Pasqal Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pasqal and related companies with MarketBeat.com's FREE daily email newsletter.